Hypertension Trial, Recruiting NCT02132741 Sponsor: University of Edinburgh Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT02132741
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are male or female
  • People aged between 18 and 80 years old
  • People with a body mass index (a measure of body weight relative to height) of 35 or below
  • For people with high blood pressure: those whose blood pressure reads 140/90 or higher, or who are already taking medication to treat high blood pressure
  • For people with chronic kidney disease (CKD): those whose condition meets the definition set out by the Kidney Diseases Quality Initiative guidelines (confirm with trial site)

Who may not be able to join:

  • People who are under the legal age of consent, or who are mentally or legally unable to make their own decisions
  • People who have donated 450ml of blood in the past four weeks
  • People with a past or present history of drug or alcohol misuse, including any history of intravenous (injected) drug use
  • People who have taken part in another clinical trial within the past month
  • People considered to be at high risk of HIV or hepatitis B infection
  • People who have a known eye disease, have had previous eye surgery, or have a significant prescription for glasses or contact lenses (stronger than plus or minus 6 dioptres)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Neeraj Dhaun, MD PhD, University of Edinburgh

Phone: 01312429215

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Edinburgh
Registry
ClinicalTrials.gov
Start date
16 May 2014
Est. completion
31 December 2027

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Choroidal & retinal morphology

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov